The interactions of cholesterol oxidase with its substrate and with the lipid bilayer will be explored in order to understand its substrate specificity. Cholesterol oxidase is a flavoenzyme that catalyzes the oxidation and isomerization of cholesterol to cholest-4-en-3-one. The chemistry catalyzed is well understood, yet structural knowledge of the catalytically active enzyme is at very low resolution. A model of the catalytically-active complex is described. The specific issues that will be addressed in the next grant period are: l. What happens to the hydrogen bond networks during catalysis? 2. What is the orientation of the enzyme on the membrane surface? 3. What is the conformation of the protein when cholesterol is bound? Does the active site lid undergo a rigid body hinge-like movement, or does the lid structure rearrange to pack with the steroid tail? 4. Using existing knowledge of the structure, can the substrate specificity of cholesterol oxidase be altered to develop mutants that are more specific for plant sterols than cholesterol? 5. Does the activity of cholesterol oxidase directly depend on lipid phase? Thus, the proposed experiments are aimed at elucidating the structure of the active complex of enzyme and membrane. A combination of high resolution X-ray crystallography, spectroscopy, and kinetics will be used. Cholesterol oxidase is used commercially for the determination of serum cholesterol concentrations, and it is being developed as an insecticide by the agribiochemical industry. Moreover, cholesterol oxidase is used to study the localization of cholesterol in membranes. These studies will provide a precise molecular model of the active enzyme complexed with steroid substrate. This model is important for the development of cholesterol oxidase both as an effective commercial product and as a useful tool in the study of cellular membranes, i.e., understanding the structure of lipid 'rafts' that have been implicated in cellular signaling.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL053306-08
Application #
6625324
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Ershow, Abby
Project Start
1994-12-01
Project End
2004-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
8
Fiscal Year
2003
Total Cost
$225,750
Indirect Cost
Name
State University New York Stony Brook
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Schaefer, Christin M; Lu, Rui; Nesbitt, Natasha M et al. (2015) FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis. Structure 23:21-33
Yang, Meng; Guja, Kip E; Thomas, Suzanne T et al. (2014) A distinct MaoC-like enoyl-CoA hydratase architecture mediates cholesterol catabolism in Mycobacterium tuberculosis. ACS Chem Biol 9:2632-45
Gao, Jin; Sampson, Nicole S (2014) A GMC oxidoreductase homologue is required for acetylation of glycopeptidolipid in Mycobacterium smegmatis. Biochemistry 53:611-3
Wipperman, Matthew F; Sampson, Nicole S; Thomas, Suzanne T (2014) Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol 49:269-93
Su, Chiao-Yung; London, Erwin; Sampson, Nicole S (2013) Mapping peptide thiol accessibility in membranes using a quaternary ammonium isotope-coded mass tag (ICMT). Bioconjug Chem 24:1235-47
Slayden, Richard A; Jackson, Mary; Zucker, Jeremy et al. (2013) Updating and curating metabolic pathways of TB. Tuberculosis (Edinb) 93:47-59
Thomas, Suzanne T; Sampson, Nicole S (2013) Mycobacterium tuberculosis utilizes a unique heterotetrameric structure for dehydrogenation of the cholesterol side chain. Biochemistry 52:2895-904
Wipperman, Matthew F; Yang, Meng; Thomas, Suzanne T et al. (2013) Shrinking the FadE proteome of Mycobacterium tuberculosis: insights into cholesterol metabolism through identification of an ?2?2 heterotetrameric acyl coenzyme A dehydrogenase family. J Bacteriol 195:4331-41
Thomas, Suzanne T; VanderVen, Brian C; Sherman, David R et al. (2011) Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism. J Biol Chem 286:43668-78
Thomas, Suzanne T; Yang, Xinxin; Sampson, Nicole S (2011) Inhibition of the M. tuberculosis 3?-hydroxysteroid dehydrogenase by azasteroids. Bioorg Med Chem Lett 21:2216-9

Showing the most recent 10 out of 19 publications